Last 7 days
-2.5%
Last 30 days
1.1%
Last 90 days
-7.1%
Trailing 12 Months
13.6%
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 4.4B | 4.6B | 4.7B | 0 |
2022 | 4.1B | 4.2B | 4.3B | 4.3B |
2021 | 4.4B | 4.3B | 4.2B | 4.0B |
2020 | 4.7B | 4.6B | 4.6B | 4.6B |
2019 | 4.4B | 4.4B | 4.5B | 4.6B |
2018 | 4.0B | 4.1B | 4.2B | 4.3B |
2017 | 3.8B | 3.8B | 3.9B | 3.9B |
2016 | 3.3B | 3.5B | 3.6B | 3.7B |
2015 | 2.6B | 2.7B | 2.9B | 3.2B |
2014 | 2.3B | 2.3B | 2.4B | 2.4B |
2013 | 2.2B | 2.2B | 2.3B | 2.3B |
2012 | 2.1B | 2.1B | 2.1B | 2.2B |
2011 | 1.9B | 2.0B | 2.0B | 2.0B |
2010 | 1.8B | 1.8B | 1.7B | 1.9B |
2009 | 1.8B | 1.8B | 1.8B | 1.8B |
2008 | 0 | 0 | 0 | 1.8B |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Nov 27, 2023 | christie edward m iii | acquired | - | - | 997 | - |
Nov 13, 2023 | coltharp douglas e | acquired | 441,341 | 26.55 | 16,623 | evp & chief financial officer |
Nov 13, 2023 | coltharp douglas e | sold | -710,919 | 63.39 | -11,215 | evp & chief financial officer |
Oct 17, 2023 | reidy christopher r | acquired | 258 | 64.5 | 4.00 | - |
Oct 17, 2023 | chidsey john | acquired | 34,937 | 64.58 | 541 | - |
Oct 16, 2023 | maryland patricia anne | acquired | - | - | 27.00 | - |
Oct 16, 2023 | williams terrance | acquired | - | - | 27.00 | - |
Oct 16, 2023 | herman joan e | acquired | - | - | 101 | - |
Oct 16, 2023 | reidy christopher r | acquired | - | - | 16.00 | - |
Oct 16, 2023 | chidsey john | acquired | - | - | 222 | - |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Dec 06, 2023 | CITIGROUP INC | reduced | -24.78 | -270,163 | 793,831 | -% |
Nov 24, 2023 | DEUTSCHE BANK AG\ | added | 34.25 | 354,059 | 1,421,710 | -% |
Nov 22, 2023 | KBC Group NV | unchanged | - | - | 19,000 | -% |
Nov 21, 2023 | Walleye Capital LLC | new | - | 48,422 | 48,422 | -% |
Nov 21, 2023 | COMERICA BANK | added | 8.29 | 9,095,440 | 9,097,440 | 0.05% |
Nov 21, 2023 | Walleye Trading LLC | added | 4.35 | 4,034 | 119,276 | -% |
Nov 17, 2023 | TimesSquare Capital Management, LLC | reduced | -0.91 | -1,140,000 | 65,474,000 | 1.02% |
Nov 17, 2023 | OLD NATIONAL BANCORP /IN/ | reduced | -1.03 | -48,952 | 2,620,580 | 0.08% |
Nov 16, 2023 | McIlrath & Eck, LLC | unchanged | - | -20.00 | 2,485 | -% |
Nov 16, 2023 | Financial Gravity Asset Management, Inc. | reduced | -89.71 | 418 | 520 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | vanguard group inc | 9.77% | 9,749,441 | SC 13G/A | |
Feb 06, 2023 | wellington management group llp | 9.58% | 9,558,849 | SC 13G/A | |
Jan 30, 2023 | blackrock inc. | 11.3% | 11,232,620 | SC 13G/A | |
Jan 30, 2023 | blackrock inc. | 11.3% | 11,232,620 | SC 13G/A | |
Feb 10, 2022 | vanguard group inc | 9.46% | 9,414,569 | SC 13G/A | |
Feb 04, 2022 | wellington management group llp | 10.58% | 10,524,661 | SC 13G/A | |
Jan 27, 2022 | blackrock inc. | 10.7% | 10,643,463 | SC 13G/A | |
Jan 25, 2022 | blackrock inc. | 10.7% | 10,643,463 | SC 13G/A | |
Feb 11, 2021 | william blair investment management, llc | 4.70% | 4,666,500 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 9.05% | 8,998,232 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Nov 28, 2023 | 3 | Insider Trading | |
Nov 28, 2023 | 4 | Insider Trading | |
Nov 27, 2023 | 8-K | Current Report | |
Nov 14, 2023 | 4 | Insider Trading | |
Nov 13, 2023 | 144 | Notice of Insider Sale Intent | |
Nov 01, 2023 | 10-Q | Quarterly Report | |
Oct 31, 2023 | S-3ASR | S-3ASR | |
Oct 26, 2023 | 8-K | Current Report | |
Oct 17, 2023 | 4 | Insider Trading | |
Oct 17, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 508.7B | 360.0B | 2.46% | 0.72% | 23.46 | 1.41 | 14.24% | 11.62% |
CVS | 96.7B | 347.8B | 9.25% | -26.74% | 11.1 | 0.28 | 10.34% | 159.11% |
CI | 91.1B | 189.9B | -12.37% | -22.06% | 13.64 | 1.92 | 5.24% | 22.27% |
HCA | 69.2B | 63.2B | 11.16% | 6.57% | 12.11 | 1.1 | 5.62% | 6.32% |
CNC | 39.4B | 150.1B | 4.91% | -14.72% | 16.13 | 0.26 | 6.04% | 21.35% |
MID-CAP | ||||||||
DVA | 9.8B | 11.9B | 26.82% | 43.59% | 16.13 | 0.82 | 2.36% | -10.41% |
UHS | 9.6B | 14.0B | 6.07% | 6.08% | 14.25 | 0.69 | 6.03% | -8.61% |
CHE | 8.6B | 2.2B | -1.60% | 9.83% | 35.34 | 3.88 | 4.50% | -6.69% |
ACHC | 6.7B | 2.9B | -0.53% | -12.01% | -365.93 | 2.34 | 13.16% | -106.47% |
AMN | 2.6B | 4.1B | 13.56% | -40.93% | 9.25 | 0.63 | -25.26% | -41.25% |
SMALL-CAP | ||||||||
AMEH | 1.6B | 1.3B | 4.12% | 12.39% | 34.86 | 1.17 | 27.06% | -27.04% |
ADUS | 1.5B | 1.0B | 10.48% | -13.37% | 25.78 | 1.44 | 10.84% | 30.19% |
BKD | 1.0B | 3.0B | 22.30% | 77.33% | -8.11 | 0.34 | 6.98% | 58.07% |
BEAT | 35.8M | - | 8.80% | -76.75% | -2.47 | - | - | -27.68% |
AMS | 15.8M | 20.7M | 12.00% | -11.27% | 54.39 | 0.76 | 6.53% | -78.75% |
Income Statement (Quarterly) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | 1.7% | 1,207 | 1,187 | 1,160 | 1,137 | 1,090 | 1,063 | 1,059 | 1,043 | 1,011 | 1,002 | 960 | 1,214 | 1,174 | 1,074 | 1,182 | 1,184 | 1,162 | 1,135 | 1,124 | 1,096 | 1,068 |
Costs and Expenses | 2.4% | 1,028 | 1,003 | 982 | 958 | 941 | 913 | 907 | 656 | 844 | 1,069 | 1,023 | 61.00 | 1,001 | 975 | 1,002 | 1,022 | 990 | 965 | 937 | 985 | 895 |
S&GA Expenses | -10.1% | 50.00 | 55.00 | 43.00 | 43.00 | 38.00 | 36.00 | 37.00 | 42.00 | 39.00 | 54.00 | 39.00 | 34.00 | 39.00 | 43.00 | 36.00 | 64.00 | 53.00 | 77.00 | 53.00 | 54.00 | 50.00 |
EBITDA Margin | 1.6% | 0.21* | 0.21* | 0.21* | 0.20* | 0.21* | 0.19* | 0.20* | 0.21* | 0.22* | 0.22* | 0.20* | 0.19* | 0.19* | 0.19* | 0.20* | - | - | - | - | - | - |
Interest Expenses | -1.1% | 36.00 | 36.00 | 36.00 | 38.00 | 38.00 | 60.00 | 40.00 | 40.00 | 40.00 | 42.00 | 43.00 | 46.00 | 49.00 | 46.00 | 43.00 | 45.00 | 40.00 | 38.00 | 37.00 | 37.00 | 37.00 |
Income Taxes | -7.6% | 30.00 | 33.00 | 32.00 | 32.00 | 22.00 | 23.00 | 24.00 | 23.00 | 26.00 | 28.00 | 25.00 | 38.00 | 27.00 | 12.00 | 27.00 | 27.00 | 34.00 | 24.00 | 31.00 | 29.00 | 30.00 |
Earnings Before Taxes | -4.1% | 145 | 151 | 146 | 151 | 107 | 83.00 | 110 | 71.00 | 128 | 182 | 167 | 30.00 | 127 | 60.00 | 136 | 118 | 154 | 135 | 157 | 76.00 | 140 |
EBT Margin | 4.1% | 0.13* | 0.12* | 0.11* | 0.10* | 0.11* | 0.11* | 0.12* | 0.13* | 0.13* | 0.13* | 0.11* | 0.10* | 0.10* | 0.10* | 0.12* | - | - | - | - | - | - |
Net Income | -6.7% | 85.00 | 91.00 | 88.00 | 89.00 | 45.00 | 49.00 | 88.00 | 92.00 | 100 | 113 | 107 | 86.00 | 78.00 | 34.00 | 87.00 | 68.00 | 98.00 | 91.00 | 102 | 28.00 | 89.00 |
Net Income Margin | 9.9% | 0.08* | 0.07* | 0.06* | 0.06* | 0.06* | 0.06* | 0.08* | 0.08* | 0.08* | 0.08* | 0.06* | 0.06* | 0.06* | 0.06* | 0.07* | - | - | - | - | - | - |
Free Cashflow | -33.0% | 60.00 | 90.00 | 131 | -17.70 | -74.80 | 130 | 104 | -68.80 | 54.00 | 142 | 60.00 | 140 | 84.00 | 139 | -54.20 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | 1.8% | 5,964 | 5,861 | 5,747 | 5,637 | 5,476 | 7,082 | 6,944 | 6,865 | 6,722 | 6,613 | 6,542 | 6,446 | 6,611 | 6,503 | 6,138 | 6,081 | 6,387 | 5,812 | 5,584 | 5,175 | 5,132 |
Current Assets | -1.2% | 814 | 824 | 762 | 717 | 734 | 1,032 | 950 | 921 | 910 | 859 | 1,001 | 949 | 1,174 | 1,102 | 785 | 756 | 1,077 | 845 | 683 | 662 | 638 |
Cash Equivalents | -15.1% | 100 | 118 | 85.00 | 22.00 | 60.00 | 136 | 77.00 | 49.00 | 66.00 | 73.00 | 224 | 186 | 450 | 419 | 105 | 60.00 | 422 | 222 | 56.00 | 69.00 | 57.00 |
Net PPE | - | - | - | - | - | - | - | - | - | - | - | - | - | 2,095 | 2,041 | 2,003 | 1,959 | 1,875 | 1,788 | 1,736 | 1,635 | 1,591 |
Goodwill | 0.8% | 1,281 | 1,271 | 8.00 | 1,263 | 1,247 | 2,457 | 2,457 | 1,237 | 2,418 | 2,412 | 2,319 | 1,228 | 2,319 | 2,319 | 2,312 | 1,219 | 2,305 | 2,112 | 2,112 | 2,101 | 2,081 |
Liabilities | -0.8% | 3,775 | 3,804 | 3,784 | 3,775 | 3,728 | 4,538 | 4,452 | 4,466 | 4,428 | 4,404 | 4,468 | 4,444 | 4,681 | 4,638 | 4,307 | 4,148 | 4,506 | 3,876 | 3,694 | 3,356 | 3,312 |
Current Liabilities | -2.4% | 639 | 655 | 592 | 576 | 605 | 835 | 755 | 749 | 794 | 805 | 812 | 717 | 683 | 664 | 586 | 721 | 1,109 | 753 | 768 | 673 | 610 |
Long Term Debt | -0.2% | 2,693 | 2,698 | 2,723 | 2,742 | 2,719 | 3,234 | 3,221 | 3,241 | 3,142 | 3,106 | 3,160 | 3,251 | 3,539 | 3,547 | 3,322 | 3,023 | 2,962 | 2,720 | 2,522 | 2,479 | 2,504 |
Shareholder's Equity | 45.6% | 2,148 | 1,475 | 1,926 | 1,310 | 1,217 | 2,501 | 2,448 | 2,357 | 2,261 | 2,176 | 2,043 | 1,970 | 1,896 | 1,831 | 1,797 | 1,693 | 1,671 | 1,584 | 1,617 | 1,557 | 1,544 |
Retained Earnings | - | - | - | - | 116 | - | - | - | 142 | - | - | - | -242 | - | - | - | -526 | - | - | - | -885 | - |
Additional Paid-In Capital | - | - | - | - | 1,730 | - | - | - | 2,290 | - | - | - | 2,327 | - | - | - | 2,370 | - | - | - | 2,589 | - |
Shares Outstanding | -100.0% | - | 100 | 99.00 | - | 99.00 | 99.00 | 99.00 | - | 99.00 | 99.00 | 124 | - | 124 | 124 | 123 | - | 123 | 123 | 124 | - | 123 |
Minority Interest | 8.3% | 587 | 542 | 542 | 516 | 493 | 498 | 475 | 446 | 418 | 414 | 388 | 382 | 375 | 369 | 353 | 341 | 338 | 308 | 302 | 280 | 265 |
Cashflow (Quarterly) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | -9.3% | 206,700,000 | 227,900,000 | 172,200,000 | 70,100,000 | 244,600,000 | 218,900,000 | 123,800,000 | 177,600,000 | 255,900,000 | 158,500,000 | 279,700,000 | 173,400,000 | 222,300,000 | 29,300,000 | 215,600,000 | 114,400,000 | 145,400,000 | 159,900,000 | 178,400,000 | 198,500,000 | 169,200,000 |
Share Based Compensation | 97.5% | 15,600,000 | 7,900,000 | 8,100,000 | 7,300,000 | 7,700,000 | 6,100,000 | 9,500,000 | 4,800,000 | 12,000,000 | 2,800,000 | 300,000 | 8,300,000 | 9,900,000 | 7,100,000 | 27,400,000 | 21,700,000 | 45,900,000 | 19,400,000 | 20,300,000 | 18,100,000 | 21,400,000 |
Cashflow From Investing | -23.6% | -128,500,000 | -104,000,000 | -206,400,000 | -174,300,000 | -123,200,000 | -123,100,000 | -220,700,000 | -124,000,000 | -226,000,000 | -95,600,000 | -142,700,000 | -89,700,000 | -92,100,000 | -83,000,000 | -145,700,000 | -320,100,000 | -100,100,000 | -91,500,000 | -98,200,000 | -65,300,000 | -200,400,000 |
Cashflow From Financing | 25.0% | -43,500,000 | -58,000,000 | -16,500,000 | -49,000,000 | -19,300,000 | -60,900,000 | 42,300,000 | -18,500,000 | -186,400,000 | -77,500,000 | -354,200,000 | -45,600,000 | 182,800,000 | 71,100,000 | -424,100,000 | 431,800,000 | 122,200,000 | -81,700,000 | -67,700,000 | -137,000,000 | 200,000 |
Dividend Payments | -4.5% | 14,900,000 | 15,600,000 | 14,900,000 | 27,800,000 | 27,800,000 | 28,500,000 | 27,700,000 | 27,600,000 | 27,800,000 | 29,100,000 | 27,500,000 | 27,600,000 | 27,700,000 | 29,000,000 | 27,400,000 | 26,400,000 | 26,600,000 | 28,300,000 | 26,400,000 | 24,500,000 | 24,500,000 |
Buy Backs | - | - | - | - | - | - | - | - | - | - | - | 1,200,000 | - | - | - | - | 2,100,000 | - | - | - | - | - |
Condensed Consolidated Statements of Comprehensive Income - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Statement Of Comprehensive Income And Income Statement [Abstract] | ||||
Net operating revenues | $ 1,206.9 | $ 1,089.5 | $ 3,554.4 | $ 3,211.3 |
Operating expenses: | ||||
Salaries and benefits | 658.6 | 605.6 | 1,923.8 | 1,778.9 |
Other operating expenses | 183.7 | 172.0 | 534.3 | 500.3 |
Occupancy costs | 14.2 | 12.4 | 42.3 | 41.6 |
Supplies | 53.9 | 51.1 | 159.7 | 148.2 |
General and administrative expenses | 49.8 | 37.9 | 148.6 | 111.5 |
Depreciation and amortization | 67.3 | 62.1 | 203.8 | 180.3 |
Total operating expenses | 1,027.5 | 941.1 | 3,012.5 | 2,760.8 |
Loss on early extinguishment of debt | 0.0 | 0.0 | 0.0 | 1.4 |
Interest expense and amortization of debt discounts and fees | 35.9 | 38.2 | 108.6 | 138.2 |
Other (income) expense | (0.5) | 3.6 | (6.8) | 13.6 |
Equity in net income of nonconsolidated affiliates | (1.0) | (0.7) | (2.3) | (2.6) |
Income from continuing operations before income tax expense | 145.0 | 107.3 | 442.4 | 299.9 |
Provision for income tax expense | 30.3 | 21.8 | 95.0 | 68.2 |
Income from continuing operations | 114.7 | 85.5 | 347.4 | 231.7 |
(Loss) income from discontinued operations, net of tax | (1.3) | (18.5) | (3.5) | 16.7 |
Net and comprehensive income | 113.4 | 67.0 | 343.9 | 248.4 |
Net and comprehensive income | 113.4 | 67.0 | 343.9 | 248.4 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (28.1) | (21.6) | (79.5) | (65.5) |
Less: Net income attributable to noncontrolling interests included in discontinued operations | 0.0 | 0.0 | 0.0 | (1.3) |
Less: Net and comprehensive income attributable to noncontrolling interests | (28.1) | (21.6) | (79.5) | (66.8) |
Less: Net and comprehensive income attributable to noncontrolling interests | (28.1) | (21.6) | (79.5) | (66.8) |
Net and comprehensive income attributable to Encompass Health | 85.3 | 45.4 | 264.4 | 181.6 |
Net and comprehensive income attributable to Encompass Health | $ 85.3 | $ 45.4 | $ 264.4 | $ 181.6 |
Weighted average common shares outstanding: | ||||
Basic (in shares) | 99.5 | 99.2 | 99.5 | 99.2 |
Diluted (in shares) | 101.4 | 100.5 | 101.1 | 100.3 |
Basic earnings per share attributable to Encompass Health common shareholders: | ||||
Continuing operations (in dollars per share) | $ 0.86 | $ 0.64 | $ 2.68 | $ 1.67 |
Discontinued operations (in dollars per share) | (0.01) | (0.19) | (0.04) | 0.15 |
Net income (in dollars per share) | 0.85 | 0.45 | 2.64 | 1.82 |
Diluted earnings per share attributable to Encompass Health common shareholders: | ||||
Continuing operations (in dollars per share) | 0.85 | 0.63 | 2.65 | 1.66 |
Discontinued operations (in dollars per share) | (0.01) | (0.18) | (0.03) | 0.15 |
Net income (in dollars per share) | $ 0.84 | $ 0.45 | $ 2.62 | $ 1.81 |
Amounts attributable to Encompass Health common shareholders: | ||||
Income from continuing operations | $ 86.6 | $ 63.9 | $ 267.9 | $ 166.2 |
(Loss) income from discontinued operations, net of tax | (1.3) | (18.5) | (3.5) | 15.4 |
Net and comprehensive income attributable to Encompass Health | $ 85.3 | $ 45.4 | $ 264.4 | $ 181.6 |
Condensed Consolidated Balance Sheets - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 | ||
---|---|---|---|---|
Current assets: | ||||
Cash and cash equivalents | $ 99.7 | $ 21.8 | ||
Restricted cash | 41.5 | 31.6 | ||
Accounts receivable | 535.9 | 536.8 | ||
Other current assets | 136.6 | 127.0 | ||
Total current assets | 813.7 | 717.2 | ||
Property and equipment, net | 3,186.3 | 2,939.2 | ||
Operating lease right-of-use assets | 196.8 | 212.5 | ||
Goodwill | 1,281.3 | 1,263.2 | ||
Intangible assets, net | 276.4 | 282.3 | ||
Other long-term assets | 209.8 | 222.1 | ||
Total assets | [1] | 5,964.3 | 5,636.5 | |
Current liabilities: | ||||
Current portion of long-term debt | 23.9 | 25.2 | ||
Current operating lease liabilities | 24.9 | 25.6 | ||
Accounts payable | 165.4 | 132.9 | ||
Accrued expenses and other current liabilities | 425.0 | 392.2 | ||
Total current liabilities | 639.2 | 575.9 | ||
Long-term debt, net of current portion | 2,692.7 | 2,741.8 | ||
Long-term operating lease liabilities | 183.9 | 199.7 | ||
Deferred income tax liabilities | 80.4 | 83.0 | ||
Other long-term liabilities | 178.9 | 174.2 | ||
Total liabilities | 3,775.1 | 3,774.6 | ||
Commitments and contingencies | ||||
Redeemable noncontrolling interests | 41.5 | 35.6 | ||
Shareholders’ equity: | ||||
Encompass Health shareholders’ equity | 1,560.4 | 1,310.3 | ||
Noncontrolling interests | 587.3 | 516.0 | ||
Total shareholders’ equity | 2,147.7 | 1,826.3 | ||
Total liabilities and shareholders' equity | [1] | $ 5,964.3 | $ 5,636.5 | |
|
CEO | Mr. Mark J. Tarr |
---|---|
WEBSITE | www.encompasshealth.com |
EMPLOYEES | 36900 |